GEODE CAPITAL MANAGEMENT, LLC - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 117 filers reported holding ANAPTYSBIO INC in Q1 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$7,177,589
-10.9%
399,594
+0.9%
0.00%0.0%
Q2 2023$8,055,053
-7.1%
396,020
-0.6%
0.00%0.0%
Q1 2023$8,669,322
+71311.2%
398,406
+1.7%
0.00%
-50.0%
Q4 2022$12,140
-99.9%
391,764
+6.3%
0.00%
+100.0%
Q3 2022$9,402,000
+24.8%
368,599
-0.7%
0.00%0.0%
Q2 2022$7,535,000
-14.4%
371,224
+4.3%
0.00%0.0%
Q1 2022$8,803,000
-33.0%
355,838
-5.8%
0.00%
-50.0%
Q4 2021$13,130,000
+34.9%
377,860
+5.3%
0.00%
+100.0%
Q3 2021$9,734,000
-2.3%
358,932
-6.6%
0.00%0.0%
Q2 2021$9,960,000
+17.2%
384,142
-2.6%
0.00%0.0%
Q1 2021$8,499,000
+10.8%
394,415
+10.5%
0.00%0.0%
Q4 2020$7,671,000
+38.4%
356,814
-5.0%
0.00%0.0%
Q3 2020$5,542,000
-29.0%
375,757
+7.5%
0.00%
-50.0%
Q2 2020$7,811,000
+54.6%
349,650
-2.2%
0.00%
+100.0%
Q1 2020$5,052,000
-55.7%
357,587
-49.1%
0.00%0.0%
Q4 2019$11,412,000
+2.9%
702,384
+121.5%
0.00%
-66.7%
Q3 2019$11,093,000
-37.3%
317,046
+1.1%
0.00%
-25.0%
Q2 2019$17,696,000
-12.3%
313,656
+13.5%
0.00%
-20.0%
Q1 2019$20,182,000
-37.7%
276,278
-45.6%
0.01%0.0%
Q4 2018$32,374,000
+38.1%
507,516
+116.0%
0.01%
-28.6%
Q3 2018$23,444,000
+104.7%
234,989
+45.8%
0.01%
+75.0%
Q2 2018$11,452,000
-26.3%
161,216
+8.0%
0.00%
-20.0%
Q1 2018$15,537,000
+6.0%
149,285
+2.5%
0.01%0.0%
Q4 2017$14,663,000
+427.6%
145,590
+83.1%
0.01%
+400.0%
Q3 2017$2,779,000
+104.9%
79,516
+40.3%
0.00%0.0%
Q2 2017$1,356,000
-10.9%
56,672
+3.3%
0.00%0.0%
Q1 2017$1,522,00054,8650.00%
Other shareholders
ANAPTYSBIO INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders